FDA Approves New Over-the-Counter Pain Reliever Combining Acetaminophen and Naproxen Sodium
The Food and Drug Administration has approved a new over-the-counter pain reliever in Tampa-St. Petersburg (Sarasota) that combines acetaminophen (the active ingredient in Tylenol) and naproxen sodium (the active ingredient in Aleve). This new medication, Tylenol with Naproxen, is designed…
Tampa St. Petersburg, FL, July 31, 2026 —
The U.S. Food and Drug Administration (FDA) has granted approval for a new over-the-counter pain reliever, notable for its dual-action formula. The medication, which combines acetaminophen and naproxen sodium, is now available in the Tampa-St. Petersburg (Sarasota) area.
Acetaminophen is widely recognized as the active ingredient in Tylenol, while naproxen sodium is the key component in Aleve. This new formulation, to be marketed as Tylenol with Naproxen, aims to offer consumers a readily accessible option for managing various types of minor aches and pains.
According to the product’s description, the new pain reliever is engineered to deliver fast-acting relief that can extend for up to 12 hours. The medication is indicated for use by adults and children aged 12 years and older.
The FDA’s approval signifies that the product has met the agency’s standards for safety and effectiveness for its intended use. Consumers seeking relief from common ailments such as headaches, muscle aches, minor arthritis pain, backache, the common cold, menstrual cramps, and toothache may consider this new option.
The availability of a combination product like Tylenol with Naproxen provides an alternative for individuals who may find relief from a single active ingredient insufficient, or who prefer the convenience of a single product for multi-symptom pain management. As with all over-the-counter medications, consumers are advised to read and follow the product label instructions carefully before use.
Story summarized from the original created by Justin Boggs on www.tampabay28.com, see more information here.
